We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
+27.71%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$297M
AUM Growth
+$61M
Cap. Flow
+$33.6M
Cap. Flow %
11.29%
Top 10 Hldgs %
99.17%
Holding
14
New
2
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
RDUS
Radius Health, Inc.
RDUS
+$53.8M
2
TRIV
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
+$27M

Top Sells

Rank Stock Value
1
MGNX icon
MacroGenics
MGNX
+$37.4M
2
PETX
Aratana Therapeutics, Inc.
PETX
+$9.84M

Sector Composition

Rank Sector Weight
1 Healthcare 90.69%
2 Miscellaneous 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
$75.8M 25.5%
+5,831,253
New +$53.8M
EPZM
2
DELISTED
Epizyme, Inc
EPZM
$75.1M 25.27%
2,413,819
– –
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$35.6M 11.98%
1,220,672
– –
PETX
4
DELISTED
Aratana Therapeutics, Inc.
PETX
$32.7M 11%
2,093,845
-694,320
-25% -$9.84M
TRIV
5
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$27.7M 9.31%
+1,776,692
New +$27M
EIGR
6
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$17.1M 5.75%
2,371
– –
HSTO
7
DELISTED
Histogen Inc. Common Stock
HSTO
$10.9M 3.65%
5,960
– –
ALT icon
8
Altimmune
ALT
$605M
$8.95M 3.01%
21,159
– –
VSTM icon
9
Verastem
VSTM
$654M
$7.4M 2.49%
68,057
– –
PCRX icon
10
Pacira BioSciences
PCRX
$1.03B
$3.58M 1.21%
39,025
– –
ETRM
11
DELISTED
EnteroMedics Inc.
ETRM
$1.74M 0.58%
1,060
– –
SGMO
12
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$343K 0.12%
22,487
– –
SVRA icon
13
Savara
SVRA
$1.08B
$331K 0.11%
7,498
– –
MGNX icon
14
MacroGenics
MGNX
$263M
$69K 0.02%
3,168
-1,777,787
-100% -$37.4M

Similar funds

WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

MPM Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, MPM Asset Management held 14 positions worth $297M, up 26% from $236M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

MPM Asset Management deployed $33.6M of net new capital in Q2 2014, opening 2 new positions. Its largest new stake was Radius Health, Inc.: 5,831,253 shares worth $75.8M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 100% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was MacroGenics, an estimated $37.4M trimmed.

  • MPM Asset Management's largest Q2 2014 buy was Radius Health, Inc.: 5,831,253 shares worth $75.8M.
  • MPM Asset Management's biggest Q2 2014 reduction was MacroGenics, cutting an estimated $37.4M.
  • MPM Asset Management's ten largest holdings make up 99% of its $297M portfolio in Q2 2014.
  • MPM Asset Management opened 2 new positions and closed 0 in Q2 2014.
  • MPM Asset Management's portfolio value rose 26% quarter-over-quarter to $297M.

Based on MPM Asset Management's 13F filing for Q2 2014, filed 17 Jul 2014.